No insider purchase over the last 90 days. The latest was filed 01 May 2026.
Every trade that managers of EM2 disclose to ASX is tracked on this page. The company sits in the Chemicals sector. Over the twelve months to 18 October 2026, 2 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 senior executive among the declarants.
With 2 filings in twelve months, the company is quieter than the median of 3 filings across the 2,526 companies we follow on the same exchange. The full history, which starts in 2026, counts 1 purchase against no sales.
The latest purchase dates back some time: it was published 169 days ago, on 1 May 2026.
For comparison within the same sector, see the insider buying recorded at Culp Inc. This summary is built from ASX disclosures alone and does not predict where the share price will go.
FY ended June 2025 · cache
2 of 2 declarations
EM2 is a company operating in the chemical and materials sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendations